BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 6259293)

  • 1. Studies on the inhibitory action of opiate compounds in isolated bovine adrenal chromaffin cells: noninvolvement of stereospecific opiate binding sites.
    Lemaire S; Livett B; Tseng R; Mercier P; Lemaire I
    J Neurochem; 1981 Mar; 36(3):886-92. PubMed ID: 6259293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that inhibition of nicotine-mediated catecholamine secretion from adrenal chromaffin cells by enkephalin, beta-endorphin, dynorphin (1-13), and opiates is not mediated via specific opiate receptors.
    Dean DM; Lemaire S; Livett BG
    J Neurochem; 1982 Mar; 38(3):606-14. PubMed ID: 6276506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opiate receptor-mediated inhibition of catecholamine release in primary cultures of bovine adrenal chromaffin cells.
    Saiani L; Guidotti A
    J Neurochem; 1982 Dec; 39(6):1669-76. PubMed ID: 6292366
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of opioid compounds on desensitization of the nicotinic response of isolated bovine adrenal chromaffin cells.
    Marley PD; Livett BG
    Biochem Pharmacol; 1987 Sep; 36(18):2937-44. PubMed ID: 2888465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of alpha-bungarotoxin and etorphine on acetylcholine-evoked release of endogenous and radiolabeled catecholamines from primary culture of adrenal chromaffin cells.
    Kageyama H; Guidotti A
    J Neurosci Methods; 1984 Jan; 10(1):9-16. PubMed ID: 6328131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of opiates with opioid binding sites in the bovine adrenal medulla: II. Interaction with kappa sites.
    Castanas E; Bourhim N; Giraud P; Boudouresque F; Cantau P; Oliver C
    J Neurochem; 1985 Sep; 45(3):688-99. PubMed ID: 2993510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of dynorphin with kappa opioid receptors in bovine adrenal medulla.
    Dumont M; Lemaire S
    Neuropeptides; 1985 Jul; 6(4):321-9. PubMed ID: 2864653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of isolated chromaffin cells to study basic release mechanisms.
    Livett BG; Boksa P; Dean DM; Mizobe F; Lindenbaum MH
    J Auton Nerv Syst; 1983 Jan; 7(1):59-86. PubMed ID: 6188774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenal medullary opiate receptors. Pharmacological characterization in bovine adrenal medulla and a human pheochromocytoma.
    Castanas E; Giraud P; Audigier Y; Drissi R; Boudouresque F; Conte-Devolx B; Oliver C
    Mol Pharmacol; 1984 Jan; 25(1):38-45. PubMed ID: 6323951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid receptors in bovine adrenal medulla.
    Dumont M; Lemaire S
    Can J Physiol Pharmacol; 1984 Oct; 62(10):1284-91. PubMed ID: 6095979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opiate receptor subtypes in the rat hypothalamus and neurointermediate lobe.
    Stojilković SS; Dufau ML; Catt KJ
    Endocrinology; 1987 Jul; 121(1):384-94. PubMed ID: 3036471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptors and receptor modulation in cultured chromaffin cells.
    Livett BG; Boksa P
    Can J Physiol Pharmacol; 1984 Apr; 62(4):467-76. PubMed ID: 6203633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of nicotinic receptors by opiate receptor agonists in cultured adrenal chromaffin cells.
    Kumakura K; Karoum F; Guidotti A; Costa E
    Nature; 1980 Jan; 283(5746):489-92. PubMed ID: 6243403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characterization of adrenal medullary opioid receptors. I. Binding of opioids to adrenal medullary opioid receptors].
    Murase H; Kamikubo K; Murayama M; Yasuda K; Tsurumi K; Miura K
    Nihon Naibunpi Gakkai Zasshi; 1987 Jun; 63(6):727-40. PubMed ID: 2822499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of nicotinic receptor function by opiate recognition sites highly selective for Met5-enkephalin[Arg6Phe7].
    Costa E; Guidotti A; Hanbauer I; Saiani L
    Fed Proc; 1983 Sep; 42(12):2946-52. PubMed ID: 6884531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computer modeling of subtypes of kappa opioid receptors in adrenal medulla.
    Pesce GO; Cruciani RA; Munson PJ; Rodbard D
    Eur J Pharmacol; 1990 Jul; 182(3):429-39. PubMed ID: 2171945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the glycine prodrug milacemide (2-N-pentylaminoacetamide) on catecholamine secretion from isolated adrenal medulla chromaffin cells.
    Yadid G; Zinder O; Youdim MB
    Br J Pharmacol; 1991 Nov; 104(3):760-4. PubMed ID: 1797336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proportional secretion of opioid peptides and catecholamines from adrenal chromaffin cells in culture.
    Wilson SP; Chang KJ; Viveros OH
    J Neurosci; 1982 Aug; 2(8):1150-6. PubMed ID: 7108586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of trifluoperazine on catecholamine secretion by isolated bovine adrenal medullary chromaffin cells.
    Brooks JC; Treml S
    Biochem Pharmacol; 1983 Jan; 32(2):371-3. PubMed ID: 6870962
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibitory effects of caffeine on secretagogue-induced catecholamine secretion from adrenal chromaffin cells of the guinea-pig.
    Nakazato Y; Tani Y; Teraoka H; Sugawara T; Asano T; Ohta T; Ito S
    Br J Pharmacol; 1994 Mar; 111(3):935-41. PubMed ID: 8019771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.